These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23330782)

  • 1. Ustekinumab for the treatment of nail psoriasis in heavily treated psoriatic patients.
    Vitiello M; Tosti A; Abuchar A; Zaiac M; Kerdel FA
    Int J Dermatol; 2013 Mar; 52(3):358-62. PubMed ID: 23330782
    [No Abstract]   [Full Text] [Related]  

  • 2. Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1.
    Rich P; Bourcier M; Sofen H; Fakharzadeh S; Wasfi Y; Wang Y; Kerkmann U; Ghislain PD; Poulin Y;
    Br J Dermatol; 2014 Feb; 170(2):398-407. PubMed ID: 24117389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ustekinumab in nail psoriasis and improvement in nail-associated quality of life in a population treated with ustekinumab for cutaneous psoriasis: an open prospective unblinded study.
    Rigopoulos D; Gregoriou S; Makris M; Ioannides D
    Dermatology; 2011; 223(4):325-9. PubMed ID: 22134046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab efficacy in nail psoriasis. A retrospective study in 48 patients.
    Fabroni C; Gori A; Troiano M; Prignano F; Lotti T
    J Eur Acad Dermatol Venereol; 2011 May; 25(5):549-53. PubMed ID: 20707829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ustekinumab for resistant psoriatic arthritis.
    Wallis DE; Waldron NM; Korendowych E
    J Rheumatol; 2013 Feb; 40(2):207. PubMed ID: 23378500
    [No Abstract]   [Full Text] [Related]  

  • 6. Ustekinumab in nail psoriasis: an open-label, uncontrolled, nonrandomized study.
    Patsatsi A; Kyriakou A; Sotiriadis D
    J Dermatolog Treat; 2013 Apr; 24(2):96-100. PubMed ID: 21797806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked improvement in nail psoriasis during treatment with adalimumab.
    Irla N; Yawalkar N
    Dermatology; 2009; 219(4):353-6. PubMed ID: 19851059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of nail psoriasis with adalimumab: an open label unblinded study.
    Rigopoulos D; Gregoriou S; Lazaridou E; Belyayeva E; Apalla Z; Makris M; Katsambas A; Ioannides D
    J Eur Acad Dermatol Venereol; 2010 May; 24(5):530-4. PubMed ID: 19807825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of psoriatic nails with indigo naturalis oil extract: a non-controlled pilot study.
    Lin YK; See LC; Chang YC; Huang YH; Chen JL; Tsou TC; Leu YL; Shen YM
    Dermatology; 2011; 223(3):239-43. PubMed ID: 22056841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of severe nail psoriasis with etanercept.
    Coelho JD; Diamantino F; Lestre S; Ferreira AM
    Indian J Dermatol Venereol Leprol; 2011; 77(1):72-4. PubMed ID: 21220889
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.
    Rigopoulos D; Gregoriou S; Stratigos A; Larios G; Korfitis C; Papaioannou D; Antoniou C; Ioannides D
    Br J Dermatol; 2008 Aug; 159(2):453-6. PubMed ID: 18565184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alefacept in the treatment of psoriatic nail disease: a proof of concept study.
    Parrish CA; Sobera JO; Robbins CM; Cantrell WC; Desmond RA; Elewski BE
    J Drugs Dermatol; 2006 Apr; 5(4):339-40. PubMed ID: 16673801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resident Rounds. Part III A. Serendipitous improvement in moderate to severe acne in psoriasis patients treated with ustekinumab: a two-case series.
    Jensen JD; Huynh T; Cafardi J; Sami N
    J Drugs Dermatol; 2013 Jun; 12(6):710-1. PubMed ID: 23839194
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of NAPSI and N-NAIL for evaluation of fingernail psoriasis in patients with moderate-to-severe plaque psoriasis treated using ustekinumab.
    Kim BR; Yang S; Choi CW; Youn SW
    J Dermatolog Treat; 2019 Mar; 30(2):123-128. PubMed ID: 29757042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.
    Luger TA; Barker J; Lambert J; Yang S; Robertson D; Foehl J; Molta CT; Boggs R
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):896-904. PubMed ID: 19453794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy).
    Sánchez-Regaña M; Sola-Ortigosa J; Alsina-Gibert M; Vidal-Fernández M; Umbert-Millet P
    J Eur Acad Dermatol Venereol; 2011 May; 25(5):579-86. PubMed ID: 21198950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of psoriasis with ustekinumab in patients with multiple sclerosis.
    Chang S; Chambers CJ; Liu FT; Armstrong AW
    Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriasis treated with ustekinumab in a patient with hepatitis C.
    Abuchar A; Vitiello M; Kerdel FA
    Int J Dermatol; 2013 Mar; 52(3):381-2. PubMed ID: 23414168
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of nail psoriasis-associated psoriatic arthritis successfully treated with adalimumab.
    Ikumi N; Kitamura N; Shiraiwa H; Inomata H; Nozaki T; Kuwana Y; Matsukawa Y; Hayama T; Sawada S; Takei M; Ochiai T
    Acta Dermatovenerol Croat; 2014; 22(1):65-6. PubMed ID: 24813847
    [No Abstract]   [Full Text] [Related]  

  • 20. Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year.
    Rich P; Griffiths CE; Reich K; Nestle FO; Scher RK; Li S; Xu S; Hsu MC; Guzzo C
    J Am Acad Dermatol; 2008 Feb; 58(2):224-31. PubMed ID: 18083272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.